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Although radical nephrectomy is the mainstay in the surgical management 
of renal cell carcinoma (RCC), a solitary kidney with RCC is an imperative 
indication for nephron-sparing surgery (NSS). In this rare setting, radical 
nephrectomy can potentially render the patient anephric, leading to dialy-
sis or renal transplantation. Although open surgery is still the gold stand-
ard for NSS, there has been an upsurge in the number of minimally in-
vasive NSS procedures that have demonstrated excellent long-term onco-
logic, surgical, and functional outcomes. Complex renal tumors in the set-
ting of a solitary kidney add an additional challenge to minimally invasive 
NSS. Here we describe 3 complex cases of RCC in a solitary kidney treated 
successfully by video-assisted minilaparotomy surgery-NSS. (Korean J 
Urol 2009;50:288-292)
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With the advancement of diagnostic imaging techniques, the 
indications for nephron-sparing surgery (NSS) have broadened 
owing to increased detection of incidental and asymptomatic 
small-sized tumors.1 The beneficial oncologic and functional 
outcomes of NSS for renal cell carcinoma (RCC) in patients 
with a normal contralateral kidney is well documented in the 
literature.2
  Among the indications for NSS, a solitary kidney with RCC 
is an imperative indication. However, NSS in a solitary kidney 
requires unique surgical and clinical management skills.3 Here 
we report our experience with 3 cases of video-assisted mini-
laparotomy surgery (VAMS)-NSS in a solitary kidney that re-
sulted in excellent oncologic, functional, and surgical outcomes.
CASE REPORTS
CASE 1
  A 40-year-old woman presented with a left renal paren-
chymal mass. She had undergone a right radical nephrectomy 
at another facility 12 months previously, which showed a con-
ventional type RCC, Fuhrman grade 3. Her serum creatinine 
level was 1.2 mg/dl. The finding on the computed tomography 
(CT) scan was the presence of a solitary left kidney with a 2.5 
cm solid, rim enhancing, and heterogeneously enhancing mid-
portion tumor. The tumor was completely endophytic and lo-
cated near the renal hilum adjacent to the major branches of 
the renal hilar vessels, as demonstrated in Fig. 1A. Further 
imaging study excluded nodal and venous involvement. VAMS- 
NSS was performed without perioperative complications. The 
operative time was 152 minutes, and the cold ischemic time 
was 40 minutes. Pathologic examination revealed a conven-
tional type RCC, Fuhrman grade 3, with a clearance margin 
of 0.1 cm (Fig. 1B). On day 1 following surgery, a rise of se-
rum creatinine to 1.7 mg/dl was observed; however, this de-
creased to 1.2 mg/dl by day 5, at which point the patient was 
discharged. Follow-up CT scans over a 12 month period 
showed no tumor recurrence and a well enhancing renal paren-
chyma (Fig. 1C). Her serum creatinine level has remained sta-
ble at 1.3 mg/dl.
CASE 2
  A 48-year-old woman with a horseshoe kidney was referred 
for a renal parenchymal mass. She had undergone a right 
hemi-nephrectomy at another facility 13 years previously for a 
right nonfunctioning kidney. Her serum creatinine level was 0.9 
mg/dl. CT scan revealed the presence of a remnant left kidney 
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Fig. 1. (A) Endophytic tumor. Computed tomography scan showing a solitary left kidney with a 2.5 cm solid tumor located near the 
renal hilum adjacent to the renal hilar vessels. (B) The cut surface of the specimen showing a well-demarcated, firm, solid yellowish 
mass (1.5x1.3 cm). (C) Contrasted computed tomography scan showing a well enhancing kidney without endophytic tumor recurrence.
with a 6.5 cm solid, heterogeneous lateral tumor that was elon-
gated from the mid to lower pole, as shown in Fig. 2A. There 
was no nodal or venous involvement. VAMS-NSS was per-
formed without complications. The operative time was 330 mi-
nutes, and the cold ischemic time was 85 minutes. Pathologic 
examination revealed conventional-type RCC, Fuhrman grade 
2, with clear margins (Fig. 2B). On day 3 after the procedure, 
her serum creatinine level rose to 4.3 mg/dl; however, it de-
clined to 3.4 mg/dl by day 7, at which point the patient was 
discharged. Follow-up examinations over a 21 month period 
showed no tumor recurrence along with a well enhancing pa-
renchyma, as demonstrated in Fig. 2C. Her serum creatinine 
level has remained stable at 1.1 mg/dl.
CASE 3
  A 78-year-old woman presented with a left renal paren-
chymal mass. She had undergone a right simple nephrectomy 
at another institution 30 years previously for multiple renal 
stones. She had a history of asthma, diabetes mellitus, and 
hypertension. Her serum creatinine level was 1.1 mg/dl. The 
finding on the CT scan was the presence of a solitary left kid-
ney with a 5.5 cm solid, heterogeneously enhancing upper pole 
tumor with an internal necrotic portion. The tumor was medially 
exophytic and involved the renal pelvis, as demonstrated in Fig. 
3A. Nodal and venous involvement was excluded. VAMS-NSS 
was performed without perioperative complications. The oper-
ative time was 252 minutes, and the cold ischemic time was 
60 minutes. Pathologic report showed a conventional-type RCC, 
Fuhrman grade 2, with clear margins (Fig. 3B). On day 3 after 
surgery, serum creatinine rose to 2.4 mg/dl, but decreased to 
1.7 mg/dl by day 5, at which point the patient was discharged. 
Follow-up CT scans over a 33 month period showed no tumor 
recurrence along with a well enhancing parenchyma (Fig. 3C). 
Her serum creatinine level has remained stable at 1.1 mg/dl.
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Fig. 2. (A) Computed tomography scan showing a remnant left kidney with a 6.5 cm solid mid/lower renal mass. (B) The cut surface 
of the specimen showing a well-defined, ovoid, golden yellow, soft solid mass measuring 5.5x4.1 cm. (C) Contrasted computed tomography 
scan showing a well enhancing remnant left horseshoe kidney without tumor recurrence.
DISCUSSION
  There has been a recent upsurge in the number of NSSs in 
line with increased detection of early stage renal tumors. Since 
its first introduction in 1887, NSS has borne adverse outcomes 
such as urinary leakage or fistula (1.4% to 17.4%) and paren-
chymal bleeding (0% to 7.9%).4 However, refinements in the 
surgical technique and the development of diagnostic techni-
ques have made this procedure safe and effective in tumor con-
trol with acceptable complication rates.5 Fergany et al6 de-
scribed NSS as being as effective as radical nephrectomy for 
localized RCC, providing long-term tumor control with preser-
vation of renal function. Nam et al7 reported that NSS for lo-
calized RCC has local recurrence and survival rates comparable 
with that of radical nephrectomy.
  For these reasons, NSS for RCC is now being performed at 
an increasing number of institutes for growing numbers of in-
dications, such as solitary kidney, bilateral tumors, significant 
renal insufficiency, and compromised function of the con-
tralateral kidney. In our cases, the presence of a tumor in a soli-
tary kidney was an absolute indication for NSS. Conventional 
NSS is a safe and well-established procedure; however, lengthy 
hospitalization, postoperative pain, and large skin wounds are 
shortcomings.5,8 In an attempt to overcome these problems, we 
demonstrated our procedure through VAMS-NSS.
  VAMS-NSS is a hybridized form of laparoscopic and open 
surgery that combines the advantages of both. The characteristic 
of this technique is that it utilizes a surgical traction system 
that provides enough surgical space even with a small incision. 
In addition, meticulous procedures are possible through both di-
rect vision and simultaneous magnified, telescopic vision on a 
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Fig. 3. (A) Hilar tumor. Computed tomography scan showing a solitary left kidney with a 5.5 cm solid tumor abutting the renal pelvis 
and branches of the renal hilar vessels. (B) The cut surface of the specimen showing a firm, solid, golden yellow, ill-defined mass measuring 
7.5x6x5 cm. (C) Contrasted computed tomography scan showing a well enhancing left kidney without tumor recurrence.
monitor. Other advantages of this technique are high safety 
rates and low morbidity rates owing to the non-necessity of 
pneumoperitoneum, which may increase cardiopulmonary com-
plications.9 It has been reported that increased intraperitoneal 
pressure during laparoscopic NSS may compromise renal blood 
flow and thus functional impairment of the solitary kidney.9 To 
reduce the cold ischemic time, we used a plastic entrapment 
bag. The bag is inserted through minilaparotomy, and the assis-
tant lifts the kidney up toward the surgeon. This allows delicate 
and precise handling while cooling ice is efficiently dispersed 
around the kidney. VAMS-NSS is performed in the retroperi-
toneum; therefore, it does not violate the peritoneum, thus avoi-
ding complications such as bowel adhesion or peritonitis. We 
did not experience any episodes of major bleeding or other com-
plications in our VAMS-NSS series that necessitated open con-
version. However, if significant bleeding were encountered re-
quiring open conversion, immediate conversion can take place.10
  In conclusion, VAMS-NSS is a safe and feasible surgical 
method for select patients with complex renal tumors, including 
hilar and endophytic tumors of a solitary kidney. VAMS may 
facilitate a minimally invasive, nephron-sparing approach for 
patients with complex tumors in a solitary kidney who might 
otherwise require open surgery or dialysis after total neph-
rectomy. These patients would be able to avoid or potentially 
postpone the associated morbidity of dialysis.
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